Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avidity Biosciences, Inc.

69.85
+0.16000.23%
Post-market: 69.850.00000.00%19:29 EDT
Volume:11.04M
Turnover:770.50M
Market Cap:10.27B
PE:-19.58
High:69.91
Open:69.73
Low:69.65
Close:69.69
52wk High:70.51
52wk Low:21.51
Shares:147.00M
Float Shares:113.00M
Volume Ratio:0.40
T/O Rate:9.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5671
EPS(LYR):-2.8885
ROE:-37.76%
ROA:-24.01%
PB:8.61
PE(LYR):-24.18

Loading ...

BUZZ-PepGen, Dyne rise after Novartis' $12 bln deal to buy rival Avidity

Reuters
·
Oct 27

Novartis' Avidity Deal Is a Green Light for Biotech Rally -- Barrons.com

Dow Jones
·
Oct 27

Avidity Biosciences downgraded to Neutral from Buy at Citi

TIPRANKS
·
Oct 27

Avidity Biosciences downgraded to Market Perform from Outperform at Leerink

TIPRANKS
·
Oct 27

Avidity Biosciences Inc : Leerink Partners Cuts to Market Perform From Outperform; Raises Target Price to $72 From $65

THOMSON REUTERS
·
Oct 27

Janus Henderson, Avidity Biosciences, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday

Benzinga
·
Oct 27

Avidity Biosciences Up Over 42%, on Track for Record High Close -- Data Talk

Dow Jones
·
Oct 27

Avidity Biosciences rises 42.8%

TIPRANKS
·
Oct 27

Avidity Biosciences Shares up About 43% After Novartis to Acquire Co for About $12 Bln

THOMSON REUTERS
·
Oct 27

Sector Update: Health Care Stocks Mixed Premarket Monday

MT Newswires Live
·
Oct 27

Novartis CEO Says Co Plans to Discuss Potential for Accelerated Approval With US FDA for Avidity's Fshd Therapy

THOMSON REUTERS
·
Oct 27

Novartis CEO, on Avidity Deal, Says "It's an Appropriate Risk to Take"

THOMSON REUTERS
·
Oct 27

Novartis CFO Says Avidity Deal in Line With Co's Strategy of Bolt-on Acquisitions- Conf Call

THOMSON REUTERS
·
Oct 27

BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Keysight Technologies, Keurig Dr Pepper

Reuters
·
Oct 27

BREAKINGVIEWS-Novartis finds neat M&A cure for growth pains

Reuters
·
Oct 27

Top Premarket Gainers

MT Newswires Live
·
Oct 27

Avidity Biosciences- Upon Termination of Merger With Novartis Under Certain Circumstances, Co to Pay Novartis Termination Fee of $450 Mln

THOMSON REUTERS
·
Oct 27

S&P 500 Futures Climb In Premarket Trading; Avidity Biosciences, BridgeBio Pharma Lead

Dow Jones
·
Oct 27

Bernstein Downgrades Avidity Biosciences to Market Perform From Outperform, Adjusts PT to $72 From $52

MT Newswires Live
·
Oct 27

Avidity Biosciences Inc : Raymond James Cuts to Market Perform From Strong Buy

THOMSON REUTERS
·
Oct 27